PharmaCorp Rx Inc. (TSXV:PCRX)

PharmaCorp Rx Statistics

Total Valuation

PharmaCorp Rx has a market cap or net worth of CAD 68.44 million. The enterprise value is 67.97 million.

Market Cap	68.44M
Enterprise Value	67.97M

Important Dates

The last earnings date was Friday, November 7, 2025.

Earnings Date	Nov 7, 2025
Ex-Dividend Date	n/a

Share Statistics

PharmaCorp Rx has 166.93 million shares outstanding. The number of shares has increased by 20.45% in one year.

Current Share Class	166.93M
Shares Outstanding	166.93M
Shares Change (YoY)	+20.45%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	11.65%
Owned by Institutions (%)	n/a
Float	147.47M

Valuation Ratios

The trailing PE ratio is 253.87.

PE Ratio	253.87
Forward PE	n/a
PS Ratio	3.89
PB Ratio	2.27
P/TBV Ratio	8.56
P/FCF Ratio	44.46
P/OCF Ratio	42.57
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 124.29, with an EV/FCF ratio of 44.16.

EV / Earnings	358.39
EV / Sales	3.86
EV / EBITDA	124.29
EV / EBIT	n/a
EV / FCF	44.16

Financial Position

The company has a current ratio of 2.53, with a Debt / Equity ratio of 0.14.

Current Ratio	2.53
Quick Ratio	1.74
Debt / Equity	0.14
Debt / EBITDA	7.90
Debt / FCF	2.81
Interest Coverage	-5.66

Financial Efficiency

Return on equity (ROE) is 0.61% and return on invested capital (ROIC) is -0.46%.

Return on Equity (ROE)	0.61%
Return on Assets (ROA)	-0.42%
Return on Invested Capital (ROIC)	-0.46%
Return on Capital Employed (ROCE)	-0.67%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.49
Inventory Turnover	7.59

Taxes

In the past 12 months, PharmaCorp Rx has paid 139,755 in taxes.

Income Tax	139,755
Effective Tax Rate	43.35%

Stock Price Statistics

The stock price has decreased by -31.67% in the last 52 weeks. The beta is -5.07, so PharmaCorp Rx's price volatility has been lower than the market average.

Beta (5Y)	-5.07
52-Week Price Change	-31.67%
50-Day Moving Average	0.46
200-Day Moving Average	0.49
Relative Strength Index (RSI)	40.08
Average Volume (20 Days)	226,030

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PharmaCorp Rx had revenue of CAD 17.60 million and earned 189,646 in profits. Earnings per share was 0.00.

Revenue	17.60M
Gross Profit	7.00M
Operating Income	-243,165
Pretax Income	322,383
Net Income	189,646
EBITDA	498,945
EBIT	-243,165
Earnings Per Share (EPS)	0.00

Balance Sheet

The company has 5.02 million in cash and 4.32 million in debt, giving a net cash position of 705,900 or 0.00 per share.

Cash & Cash Equivalents	5.02M
Total Debt	4.32M
Net Cash	705,900
Net Cash Per Share	0.00
Equity (Book Value)	30.21M
Book Value Per Share	0.26
Working Capital	5.12M

Cash Flow

In the last 12 months, operating cash flow was 1.61 million and capital expenditures -68,248, giving a free cash flow of 1.54 million.

Operating Cash Flow	1.61M
Capital Expenditures	-68,248
Free Cash Flow	1.54M
FCF Per Share	0.01

Margins

Gross margin is 39.77%, with operating and profit margins of -1.38% and 1.08%.

Gross Margin	39.77%
Operating Margin	-1.38%
Pretax Margin	1.83%
Profit Margin	1.08%
EBITDA Margin	2.83%
EBIT Margin	-1.38%
FCF Margin	8.74%

Dividends & Yields

PharmaCorp Rx does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.45%
Shareholder Yield	-20.45%
Earnings Yield	0.28%
FCF Yield	2.25%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6